Amphastar Pharmaceuticals Inc vs GameStop Corp. — how do they compare? Amphastar Pharmaceuticals Inc trades at $19.63 (market cap $868.62M), while GameStop Corp. trades at $18.49 (market cap $8.44B). The key difference: GameStop Corp. is far larger — about 9.7× Amphastar Pharmaceuticals Inc's market cap, and Amphastar Pharmaceuticals Inc is trading nearer its 52-week high, GameStop Corp. nearer its low. Which is the better fit depends on your goals.
| AMPH | GME | |
|---|---|---|
Market Cap | $868.62M | $8.44B |
Sector | Health | Consumer Cyclical |
52-Week High | $30.81 | $27.69 |
52-Week Low | $16.87 | $18.79 |
Enterprise Value | $1.27B | $4.42B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GME trades at $18.79, down 1.93% today, with a bearish technical signal from moving averages but oversold RSI readings. Recent earnings beats and a net income margin of 20.45% highlight improving profitability, though revenue declined to $3.82B in 2025. News indicates potential shifts in the proposed eBay acquisition strategy, moving toward a partnership instead of a full takeover.
The outlook is mixed: strong earnings momentum and low debt-to-asset ratio of 0.28 support upside, but bearish analyst consensus (16.67% buy) and revenue contraction pose risks. Investors face dilution concerns from a $1.4B debt-for-stock swap, while collectibles growth offers opportunity.
Trailing returns across standard periods
Latest headlines on both assets
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →Global Market Group Ltd. operates an Internet website that connects Chinese manufacturers with international buyers. The Company's customers can post company profiles and product information in standardized formats; post product listings; and trade leads.
Read more on GME →